top of page
Contingent Value Rights: Bridging Valuation Gaps in Biotech M&A Deals
In biotech M&A, Contingent Value Rights (CVRs) bridge valuation gaps by tying compensation to future milestones.
Timothy Chan
6 min read
bottom of page
top of page
bottom of page